Fresenius Kabi USA, LLC recalls Glycopyrrolate Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of Particulate Matter: Hair was found in product
- Products
-
- Glycopyrrolate Injection
- Company
- Fresenius Kabi USA, LLC
- Where it was sold
-
Nationwide within in the USA
Nationwide
- Units affected
- 59,425 vials
- About this recall
- Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07